Filter
2675
Filtered Results: 2675
Text search:
Global
Drug
Facility
Featured
Recommendations
263
New Publications
862
Language
Document type
No document type
1655
Guidelines
367
Studies & Reports
360
Manuals
113
Strategic & Response Plan
97
Training Material
31
Fact sheets
28
Situation Updates
13
Resource Platforms
6
Infographics
3
Brochures
1
App
1
Countries / Regions
India
136
Kenya
99
Global
82
Ethiopia
82
Nigeria
75
South Africa
74
Uganda
72
Tanzania
64
Malawi
59
Nepal
58
Liberia
55
Sierra Leone
50
Zambia
50
Ghana
48
Bangladesh
41
Western and Central Europe
40
Myanmar / Burma
39
Rwanda
36
Namibia
33
Africa
31
Eastern Europe
28
Ukraine
27
Zimbabwe
26
Lesotho
25
Asia
25
Cambodia
24
Philippines
23
Latin America and the Carribbean
23
South–East Asia Region
18
Syria
16
Senegal
15
Burkina Faso
15
Mozambique
15
Congo, Democratic Republic of
15
Botswana
15
Indonesia
15
Russia
12
Cameroon
11
East and Southern Africa
9
Eswatini/ Swaziland
9
South Sudan
8
Pakistan
8
Tajikistan
6
Benin
6
Haiti
6
West and Central Africa
6
Middle East and North Africa
6
Colombia
5
Laos
5
Guinea
5
Venezuela
5
Western Pacific Region
5
Eastern Europe and Central Asia
5
Sudan
5
Yemen
5
Thailand
4
Mexico
4
El Salvador
4
China
4
Afghanistan
4
Germany
4
Sri Lanka
4
Peru
3
Vietnam
3
Brazil
3
Moldova
3
Palestine
3
Georgia
3
Central African Republic
3
Libya
3
Somalia
3
North Macedonia
2
Timor Leste/ East Timor
2
Chile
2
Iran
2
Albania
2
Armenia
2
USA
2
Jordan
2
Gabon
2
France
2
Côte d’Ivoire / Ivory Coast
2
Lebanon
2
Papua New Guinea
2
Mali
2
Bhutan
2
Iraq
2
Madagascar
2
Serbia
1
Turkey
1
Gambia
1
Kazakhstan
1
Kyrgyzstan
1
Congo-Brazzaville
1
Niger
1
Uzbekistan
1
Morocco
1
Mongolia
1
Qatar
1
Bulgaria
1
Lithuania
1
Ireland
1
Saudi Arabia
1
Turkmenistan
1
Denmark
1
Maldives
1
Tunisia
1
United Kingdom
1
Portugal
1
Spain
1
Argentina
1
Romania
1
Greece
1
Ecuador
1
Authors & Publishers
Publication Years
Category
Countries
1208
Clinical Guidelines
239
Public Health
129
Women & Child Health
111
Key Resources
107
Capacity Building
46
Pharmacy & Technologies
36
Toolboxes
TB
340
HIV
296
AMR
157
COVID-19
125
Mental Health
96
Pharmacy
75
NTDs
72
Caregiver
57
Rapid Response
55
NCDs
40
Conflict
35
Ebola & Marburg
33
Planetary Health
29
Refugee
27
Health Financing Toolbox
23
Global Health Education
23
Disability
21
Polio
15
Cholera
11
Natural Hazards
9
Specific Hazards
6
Malaria
6
Zika
3
Social Ethics
2
PLOS Glob Public Health 4(12): e0004035. https://doi. org/10.1371/journal.pgph.0004035.
A new formulation of praziquantel, arpraziquantel (arPZQ), has been developed for preschool-
aged children (PSAC) to fill the treatment gap for this age group in schistosomiasis control and
elimination program...
First WHO Global Ministerial Conference
Ending TB in the Sustainable Development Era: A Multisectoral Response
Moscow, Russian Federation, 16-17 November 2017
The document provides a comprehensive overview of malaria, covering its global impact, transmission, symptoms, diagnosis, treatment, prevention strategies, and the role of public health interventions—especially in high-risk regions like sub-Saharan Africa—to reduce its incidence and mortality.
Guidelines for treatment of drug-susceptible tuberculosis and patient care
Uptsate 2017
Division of Global Migration and Quarantine
April 16, 2012
The Global Action Plan on Antimicrobial Resistance (AMR) calls for making AMR a core component of professional education and training. In 2018, the World Health Organization (WHO) published Competency framework for health workers’ education and training on AMR to ensure that academic institutions ...
Antimicrobial resistance (AMR) is a global human, animal, plant and environment health threat that needs to be addressed by every country. The impacts of AMR are wide-ranging in terms of human health, animal health, food security and safety, environmental effects on ecosystems and biodiversity, and ...
Global and Regional Data 1 December 2021; The 90–90–90 targets were missed, but not by much. At the end of 2020, 84% of people living with HIV knew their HIV status, 87% of people living with HIV who knew their HIV status were accessing antiretroviral therapy, and 90% of people on treatment were...
WHO/Europe has launched a new guide, providing support to countries on how to apply behavioural and cultural insights (BCI) for health. It presents a simple step-wise approach, complemented by a rich collection of detailed considerations, tools and exercises. The guide is the first of its kind, spec...
Language influences the way we think, how we perceive reality, and how we behave. With respect to HIV, language can embody stigma and discrimination, which impacts access to testing, acquisition of HIV, and engagement with treatment. Language plays a role in supporting respect and empowerment of ind...
The Global Antibiotic Resistance Partnership (GARP)-Mozambique team, in partnership with the Center for Disease Dynamics, Economics & Policy (CDDEP), has produced this report as part of a solid com-mitment to develop actionable policy proposals to tackle antibiotic resistance and improve appropriate...
Essential Drug list on page 36!!
Mpox is an emerging zoonotic disease caused by the mpox virus, a member of the Orthopoxvirus genus closely related to the variola virus that causes smallpox. Mpox was first discovered in 1958 when outbreaks of a pox-like disease occurred in monkeys kept for research. The first human case was recorde...
Global HIV Strategic Information Working Group
For Populations At Risk For HIV
Global concerns: Implications for the future
Child Mental Health Atlas
BMJ Global Health, Vol.5 No. 12Spatial subdivision of the camp (‘sectoring’) was able to ‘flatten the curve’, reducing peak infection by up to 70% and delaying peak infection by up to several months. The use of face masks coupled with the efficient isolation of infected individuals reduced t...
In 1964 medical mission was challenged and called to define its distinctiveness and its special role in the context of that particular time. The consultation "Tuebingen I" clearly stated: "The Christian church has a specific task in the field of health and healing"1, and developed a conce...
WHO’s Country Cooperation Strategy (CCS) defines the Organization’s medium-term vision for working in and with a particular country. The CCS, developed in the context of global and national health priorities, examines the overall health situation in a country, including the state of the health s...
Diabetes is a significant public health issue that affects approximately one in 10 adults globally, with type 2 diabetes accounting for 90–95% of cases. This chronic condition causes considerable morbidity and mortality and is growing in impact, with cases projected to rise from 537 million in 202...
Care for persons with noncommunicable diseases (NCDs), such as cardiovascular disease, diabetes, cancer, and chronic obstructive pulmonary disease, is a major health priority for most countries worldwide, particularly for low-middle income countries where the problem seems to be worsening. Globally,...
